Announcements Trials
Browse Landscape

Status

Active not recruiting 2Unknown 1

Sponsor Class

OTHER 1INDUSTRY 1FED 1

Study Type

Interventional 147Observational 3Expanded_access 2

Sponsor

Cancer Type

Plasma cell 2Sarcoma 1Lymphoid 1

Conditions

Multiple Myeloma 2Lymphoma, T-Cell 1Lymphoma 1Dendritic Cell Sarcoma, Interdigitating 1

Interventions

Surveys and Questionnaires 543Blood Specimen Collection 446Surgical Procedures, Operative 164Observation 152Drug Therapy 142Radiotherapy 141Interviews as Topic 139Gene Expression Profiling 129Biopsy 117Magnetic Resonance Spectroscopy 116Immunohistochemistry 112Data Collection 95Polymerase Chain Reaction 87Specimen Handling 81Amplified Fragment Length Polymorphism Analysis 81Bevacizumab 78Microarray Analysis 76Flow Cytometry 69Neoadjuvant Therapy 68Watchful Waiting 66Magnetic Resonance Imaging 65Immune Checkpoint Inhibitors 61Nivolumab 60Immunotherapy 57Therapeutics 55Reverse Transcriptase Polymerase Chain Reaction 52pembrolizumab 50Ultrasonography 47Positron Emission Tomography Computed Tomography 47Hematologic Tests 46

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Observational × selinexor × Clear all
NCT05954780 2026-01-14

SEATTLE

iOMEDICO AG

Active not recruiting
75 enrolled
Plasma cell

Multiple Myeloma

NCT06452446 2025-02-10

Selinexor

Durham VA Medical Center

Active not recruiting
20 enrolled
Plasma cellSarcoma

Multiple Myeloma, Dendritic Cell Sarcoma, Interdigitating

NCT05852028 2023-05-10

A Real-world Study of Selinexor-based Regimens for Treatment of Non-Hodgkin Lymphoma

Ruijin Hospital

Unknown
250 enrolled
Lymphoid

Lymphoma, Lymphoma, T-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡